Onconova Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Onconova Therapeutics's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $226,000. Profit margin reached -8384%. Total operating expenses were $20,524,000.
Profit Margin
| 2014 | 800K | -63.68M | -7960.25% |
|---|---|---|---|
| 2015 | 11.45M | -23.97M | -209.31% |
| 2016 | 5.54M | -19.66M | -354.62% |
| 2017 | 787K | -24.09M | -3061.25% |
| 2018 | 1.22M | -20.57M | -1675.33% |
| 2019 | 2.18M | -21.50M | -985.02% |
| 2020 | 231K | -25.15M | -10890.48% |
| 2021 | 226K | -15.82M | -7003.54% |
| 2022 | 226K | -18.30M | -8097.79% |
| 2023 | 226K | -18.94M | -8384.07% |
ONTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 226K | 226K | 226K | 231K | 2.18M | 1.22M | 787K | 5.54M | 11.45M | 800K |
Cost of revenue | -225.99B | 14K | 14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 226B | 212K | 212K | 231K | 2.18M | 1.22M | 787K | 5.54M | 11.45M | 800K |
Operating exp. | ||||||||||
Research and development | 11.43M | 11.40M | 7.29M | 16.89M | 15.53M | 16.92M | 19.11M | 20.07M | 25.89M | 49.42M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 20.52M | 19.85M | 16.72M | 25.22M | 23.88M | 24.51M | 26.52M | 29.24M | 35.42M | 64.54M |
Operating income | -20.29M | -19.62M | -16.49M | -24.99M | -21.69M | -23.28M | -25.73M | -23.70M | -23.97M | -63.74M |
Other income (expenses), net | 1.35M | 663K | 333K | -160K | 206K | 2.74M | 1.65M | 4.05M | -35K | -32K |
Income before tax | -18.94M | -18.96M | -16.16M | -25.15M | -21.49M | -20.53M | -24.07M | -19.65M | -24.00M | -63.77M |
Income tax expense | 0 | -663K | -335K | 4K | 10K | -124K | 13K | 14K | 16K | 19K |
Net income | -18.94M | -18.30M | -15.82M | -25.15M | -21.50M | -20.57M | -24.09M | -19.66M | -23.97M | -63.68M |
Earnings per share | ||||||||||
Basic EPS | -0.9 | -0.88 | -0.94 | -2.17 | -22.42 | -53.37 | -602.28 | -999.64 | -2.37K | -6.61K |
Diluted EPS | -0.9 | -0.88 | -0.94 | -2.17 | -22.42 | -53.37 | -602.28 | -999.64 | -2.37K | -6.61K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |